Oramed Pharmaceuticals Inc (ORMP)

Currency in ILS
737
-10(-1.34%)
Closed·
ORMP Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected in 13 days
Fair Value
Day's Range
730760
52 wk Range
695999
Key Statistics
Bid/Ask
731.00 / 745.00
Prev. Close
737
Open
748
Day's Range
730-760
52 wk Range
695-999
Volume
4.49K
Average Volume (3m)
10.87K
1-Year Change
-22.1%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ORMP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Oramed Pharmaceuticals Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Oramed Pharmaceuticals Inc Company Profile

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.

Compare ORMP to Peers and Sector

Metrics to compare
ORMP
Peers
Sector
Relationship
P/E Ratio
−3.2x−5.3x−0.5x
PEG Ratio
0.010.000.00
Price/Book
0.6x2.8x2.6x
Price / LTM Sales
44.5x2.5x3.3x
Upside (Analyst Target)
-126.9%42.4%
Fair Value Upside
Unlock13.8%7.2%Unlock

Earnings

Latest Release
May 28, 2025
EPS / Forecast
-0.19 / -0.05
Revenue / Forecast
2.00M / 500.00K
EPS Revisions
Last 90 days

ORMP Income Statement

People Also Watch

0.3650
VXRT
-8.50%
25.79
CNC
+1.02%
13.470
HMY
-4.06%
57.81
TEM
-0.82%
181.54
BDX
-0.46%

FAQ

What Stock Exchange Does Oramed Pharmaceuticals Inc Trade On?

Oramed Pharmaceuticals Inc is listed and trades on the Tel Aviv Stock Exchange stock exchange.

What Is the Stock Symbol for Oramed Pharmaceuticals Inc?

The stock symbol for Oramed Pharmaceuticals Inc is "ORMP."

What Is the Oramed Pharmaceuticals Inc Market Cap?

As of today, Oramed Pharmaceuticals Inc market cap is 294.49M.

What Is Oramed Pharmaceuticals Inc's Earnings Per Share (TTM)?

The Oramed Pharmaceuticals Inc EPS (TTM) is -0.69.

When Is the Next Oramed Pharmaceuticals Inc Earnings Date?

Oramed Pharmaceuticals Inc will release its next earnings report on 12 Aug 2025.

From a Technical Analysis Perspective, Is ORMP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Oramed Pharmaceuticals Inc Stock Split?

Oramed Pharmaceuticals Inc has split 0 times.

How Many Employees Does Oramed Pharmaceuticals Inc Have?

Oramed Pharmaceuticals Inc has 4 employees.

What is the current trading status of Oramed Pharmaceuticals Inc (ORMP)?

As of 31 Jul 2025, Oramed Pharmaceuticals Inc (ORMP) is trading at a price of 737.00, with a previous close of 737.00. The stock has fluctuated within a day range of 730.00 to 760.00, while its 52-week range spans from 695.00 to 999.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.